Relistor

Salix Pharmaceuticals, Inc.🇺🇸 United States

FDA Page

Effective Date: May 1, 2024
Approval ID: c488fb7c-0a5b-487c-b452-996809d1cb99
Products: 3 registered
Version: 68

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use RELISTOR safely and effectively. See full prescribing information for RELISTOR. RELISTOR(methylnaltrexone bromide) tablets, for oral use RELISTOR(methylnaltrexone bromide) injection, for subcutaneous use Initial U.S. Approval: 2008

Quick Stats

Total Products3

Labelers2

Label Sections22

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.